Peripheral blood abnormalities and bone marrow infiltration in canine large B-cell lymphoma: is there a link?
暂无分享,去创建一个
[1] N. Eberle,et al. Flow cytometric evaluation of peripheral blood and bone marrow and fine-needle aspirate samples from multiple sites in dogs with multicentric lymphoma. , 2012, American journal of veterinary research.
[2] Ming-Sun Yu,et al. Prognostic value of platelet count in diffuse large B-cell lymphoma. , 2012, Clinical lymphoma, myeloma & leukemia.
[3] Paul R. Avery,et al. Class II major histocompatibility complex expression and cell size independently predict survival in canine B-cell lymphoma. , 2011, Journal of veterinary internal medicine.
[4] M. Gelain,et al. Use of flow cytometric immunophenotyping to refine the cytological diagnosis of canine lymphoma. , 2011, Veterinary journal.
[5] L. Marconato,et al. Predictors of long-term survival in dogs with high-grade multicentric lymphoma. , 2011, Journal of the American Veterinary Medical Association.
[6] J. Byrd,et al. Non-Hodgkin's lymphomas. , 2010, Journal of the National Comprehensive Cancer Network : JNCCN.
[7] C. Khanna,et al. Response evaluation criteria for peripheral nodal lymphoma in dogs (v1.0)--a Veterinary Cooperative Oncology Group (VCOG) consensus document. , 2010, Veterinary and comparative oncology.
[8] B. Shadbolt,et al. Routine use of ancillary investigations in staging diffuse large B-cell lymphoma improves the International Prognostic Index (IPI) , 2009, Journal of hematology & oncology.
[9] P. Morley,et al. Anemia is associated with decreased survival time in dogs with lymphoma. , 2008, Journal of veterinary internal medicine.
[10] L. Marconato,et al. Cytosine arabinoside in addition to VCAA-based protocols for the treatment of canine lymphoma with bone marrow involvement: does it make the difference? , 2008, Veterinary and comparative oncology.
[11] Paul R. Avery,et al. Canine lymphoproliferative disease characterized by lymphocytosis: immunophenotypic markers of prognosis. , 2008, Journal of veterinary internal medicine.
[12] M. Mazzilli,et al. Aberrant phenotypes and quantitative antigen expression in different subtypes of canine lymphoma by flow cytometry. , 2008, Veterinary immunology and immunopathology.
[13] M. D. Lucroy,et al. Assessment of anemia as an independent predictor of response to chemotherapy and survival in dogs with lymphoma: 96 cases (1993-2006). , 2007, Journal of the American Veterinary Medical Association.
[14] H. Erb,et al. Stage migration in dogs with lymphoma. , 2007, Journal of veterinary internal medicine.
[15] K. Chalvet-Monfray,et al. Prognostic significance of morphological subtypes in canine malignant lymphomas during chemotherapy. , 2004, Veterinary journal.
[16] A. Morávková,et al. Flow cytometric analysis of bone marrow leukocytes in neonatal dogs. , 2003, Veterinary immunology and immunopathology.
[17] T. Habermann,et al. Immunophenotypic analysis of peripheral blood and bone marrow in the staging of B-cell malignant lymphoma. , 1999, Blood.
[18] M. Kiupel,et al. Prognostic Factors for Treated Canine Malignant Lymphoma , 1999, Veterinary pathology.
[19] E. Breitschwerdt,et al. Immunophenotypic comparison of blood and lymph node from dogs with lymphoma. , 1998, Veterinary clinical pathology.